SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-18-013641
Filing Date
2018-05-15
Accepted
2018-05-15 16:21:39
Documents
8
Effectiveness Date
2018-05-15

Document Format Files

Seq Description Document Type Size
1 S-8 acer-s8.htm S-8 140561
2 EX-4.1 acer-ex41_65.htm EX-4.1 5716
3 EX-5.1 acer-ex51_7.htm EX-5.1 6733
4 EX-23.1 acer-ex231_6.htm EX-23.1 3540
5 EX-99.6 FORM OF NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AGREEMENT FOR OPTI acer-ex996_66.htm EX-99.6 84883
6 GRAPHIC g201805151309400655382.jpg GRAPHIC 104735
7 GRAPHIC g201805151309397974863.jpg GRAPHIC 2231
8 GRAPHIC g201805151309400925383.jpg GRAPHIC 59217
  Complete submission text file 0001564590-18-013641.txt   472121
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-224942 | Film No.: 18836841
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1